Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cannabidiol,Aspartame
Therapeutic Area : Dermatology
Study Phase : Approved
Sponsor : CURE Pharmaceutical
Deal Size : $44.0 million
Deal Type : Acquisition
CURE Pharmaceutical to Acquire Sera Labs in a $20 Million Transaction
Details : Acquisition of Sera Labs will add to CURE a growing brand portfolio and monetization platform that fits remarkably well with CURE’s development capabilities, products, and existing market verticals.
Brand Name : Seratopical
Molecule Type : Small molecule
Upfront Cash : $20.0 million
July 28, 2020
Lead Product(s) : Cannabidiol,Aspartame
Therapeutic Area : Dermatology
Highest Development Status : Approved
Sponsor : CURE Pharmaceutical
Deal Size : $44.0 million
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?